Latest News
|
16 May 2013
0 Likes 
The US Food and Drug Administration (FDA) may be at the forefront of trying to prevent the misuse and abuse of opioid painkillers, but as two Federal Register notices this week point out, it's not the
Read More...
Latest News
|
12 July 2012
0 Likes
A report in the New England Journal of Medicine (NEJM) found abuse of a OxyContin, a branded version of the opioid oxycodone, went down significantly between 2010 and the first quarter of 2012 as the
Read More...
Latest News
|
9 July 2012
0 Likes
The US Food and Drug Administration (FDA) announced 9 July the approval of a new Risk Evaluation and Mitigation Strategy (REMS) for the most potent opioid products on the market, saying in a statement
Read More...
Latest News
|
8 June 2012
0 Likes
The US Food and Drug Administration (FDA) is planning to revisit a benefit:risk assessment for a powerful painkiller subject to escalating amounts of addiction and abuse after the agency was pressed
Read More...
Latest News
|
20 March 2012
0 Likes
Scientific agencies like the US Food and Drug Administration (FDA) are under increasing pressure from “corporate abuse” of the political and legal processes, claims a new report from the Union of
Read More...
Latest News
|
29 December 2011
0 Likes
Starting Sunday, California consumers hoping to purchase products containing dextromethorphan—commonly found in Robitussin-DM, Mucinex-DM, and Nyquil—will have to show proof that they are over 18
Read More...